Lytix Biopharma is a clinical-stage immuno-oncology company developing novel cancer immunotherapies, an area within cancer therapy that is aimed at activating the patient’s immune system to fight cancer. Lead compound LTX-315 provides access to antigens by using the patient’s own tumor as source of antigens and turns cold tumors hot. Local treatment with LTX-315 targets the first step in the cancer immunity cycle with a potential cornerstone position in immunotherapy.
View Top Employees from Lytix Biopharma| Website | http://www.lytixbiopharma.com/ |
| Revenue | $2 million |
| Employees | 19 (18 on RocketReach) |
| Founded | 2003 |
| Address | 23 Sykehusvegen, Tromso, Troms 9019, NO |
| Phone | (477) 764-8900 |
| Technologies |
JavaScript,
HTML,
Google Analytics
+15 more
(view full list)
|
| Industry | Biotechnology, Manufacturing General, Drug Discovery, Manufacturing, Science and Engineering, Drug Delivery, Health Care, Pharmaceutical |
| Web Rank | 2 Million |
| Keywords | Lytix Biopharma, Lytix Biopharma Co Development Program Nasal Decolonization, Itn Luxembourg Immuno Oncology, Nct01986426, Ltx-109 |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Lytix Biopharma employee's phone or email?
Lytix Biopharma Questions
The Lytix Biopharma annual revenue was $2 million in 2024.
Stephen Worsley is the Chief Business Officer of Lytix Biopharma.
18 people are employed at Lytix Biopharma.
Lytix Biopharma is based in Tromso, Troms.
The NAICS codes for Lytix Biopharma are [325, 32541, 32, 3254].
The SIC codes for Lytix Biopharma are [283, 28].
Top Lytix Biopharma Employees
-
5+3
-
22
-
2
-
21
-
1
-
2
-
25+
Related Companies
